BioMark Diagnostics's total assets for Q3 2026 were C$2.14M, an increase of 13.76% from the previous quarter. TSE:BUX total liabilities were C$1.63M for the fiscal quarter, a 60.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.